Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / *W EXP 10/01/202
-
Total 13F shares
-
5,962,164
-
Share change
-
-317,752
-
Total reported value
-
$436,419
-
Price per share
-
$0.07
-
Number of holders
-
29
-
Value change
-
-$25,365
-
Number of sells
-
4
Institutional Holders of Baird Medical Investment Holdings Ltd - *W EXP 10/01/202 (BDMDW) as of Q3 2025
As of 30 Sep 2025,
Baird Medical Investment Holdings Ltd - *W EXP 10/01/202 (BDMDW) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,962,164 shares.
The largest 10 holders included
Clear Street Group Inc., Sculptor Capital LP, ARISTEIA CAPITAL, L.L.C., Calamos Advisors LLC, Linden Advisors LP, Kepos Capital LP, ADAGE CAPITAL PARTNERS GP, L.L.C., Davidson Kempner Capital Management LP, GOLDMAN SACHS GROUP INC, and WOLVERINE ASSET MANAGEMENT LLC.
This page lists
29
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.